✦ LIBER ✦

O.061 Lamivudine treatment for acute hepatitis B — a randomized controlled trial

✍ Scribed by S.K. Sarin; M. Kumar; S. Sathpathy; S. Hissar; R. Chauhan; R. Monga; K. Das; C. Pandey; B.C. Sharma

Book ID: 117770108
Publisher: Elsevier Science
Year: 2006
Tongue: English
Weight: 274 KB
Volume: 36
Category: Article
ISSN: 1386-6532
DOI: 10.1016/s1386-6532(06)80066-1

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A randomized controlled trial of lamivud

A randomized controlled trial of lamivudine to treat acute hepatitis B

✍ M. Kumar; S. Satapathy; R. Monga; K. Das; S. Hissar; C. Pande; B. C. Sharma; S. 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 193 KB 👁 1 views

The role of antivirals in patients with acute viral hepatitis B (AVH-B) has not been evaluated in controlled trials. The aim of this study was to evaluate the efficacy of lamivudine in patients with AVH-B. AVH-B patients with serum bilirubin of more than 5 mg/dL were randomized to receive either 100

Lamivudine and interferon versus lamivud

Lamivudine and interferon versus lamivudine monotherapy for HBeAg-Positive hepatitis B treatment: A meta-analysis of randomized, controlled trials

✍ Dan Rudin 📂 Article 📅 2007 🏛 Springer Healthcare Communications 🌐 English ⚖ 225 KB

Recommendation of lamivudine-to-entecavi

Recommendation of lamivudine-to-entecavir switching treatment in chronic hepatitis B responders: Randomized controlled trial

✍ Kentaro Matsuura; Yasuhito Tanaka; Atsunori Kusakabe; Shuhei Hige; Jun Inoue; Ma 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 260 KB

Interferon and lamivudine vs. interferon

Interferon and lamivudine vs. interferon for hepatitis B e antigen-positive hepatitis B treatment: meta-analysis of randomized controlled trials

✍ Dan Rudin; Sooraj M. Shah; Alexander Kiss; Robert V. Wetz; Vincent M. Sottile 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 119 KB

Lamivudine treatment for acute severe he

Lamivudine treatment for acute severe hepatitis B: a pilot study

✍ H. Schmilovitz-Weiss; Z. Ben-Ari; E. Sikuler; E. Zuckerman; W. Sbeit; Z. Ackerma 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 119 KB

(+)-Cyanidanol-3 in the Treatment of Acu

(+)-Cyanidanol-3 in the Treatment of Acute Viral Hepatitis: A Randomized Controlled Trial

✍ Hans Schomerus; Karl H. Wiedmann; Wolfgang Dölle; Herrmann Peerenboom; Georg Str 📂 Article 📅 1984 🏛 John Wiley and Sons 🌐 English ⚖ 461 KB 👁 1 views

One-hundred sixty patients (81 cyanidanol, 79 placebo) were included in a double-blind placebo-controlled clinical trial to evaluate the effect of 3 gm (+)-cyanidanol-3 per day for 8 weeks on the clinical course of acute viral hepatitis and HBsAg elimination. Quantitative determination of HBsAg was